fda compounding semaglutide warning letter news Drugmakers battle pharmacies over compounded Ozempic and Zepbound : Shots FDA issues 30 warning letters
Description
Titration is important
At 2.5 mg weekly, most people experience mild effects
Prescribing semaglutide for weight loss in nondiabetic, obese patients is associated with an increased risk of erectile dysfunction: a TriNetX database study
These side effects include: Nausea Vomiting Diarrhea Constipation Stomach pain, bloating, or discomfort Feeling overly full after eating small amounts of food For many people, these symptoms ease over time as the body adapts
Some are drawn to it for ongoing weight management and because of the cost
